Dime La VerDAD: Verify, Debunk, and Disseminate
Dime La VerDAD is an innovative social media capacity-building program that empowers promotores de salud to debunk vaccine misinformation through the use of personal narratives on social media. The core of the implementation strategy consists of augmenting training and self-efficacy for natural community champions, "promotores de salud" from the Hispanic community as trusted messengers to debunk vaccination misinformation. The study will leverage existing community relationships in Chicago and a first of its kind misinformation curriculum to debunk misinformation in communities served by participating promotores de salud. Dime La VerDAD (Verify, Debunk, and Disseminate) is an innovative social media capacity-building program based on theoretical frameworks related to health communication that empowers promotores de salud to debunk vaccine misinformation through the use of personal narratives on social media. This mixed methods study will use a rigorous stepped wedge design to 1) deliver a scalable program of science communicators using an adapted curriculum grounded in infodemiology, 2) evaluate how debunking misinformation is perceived on social media, and 3) discern how use of personal narratives to enhance science communication can lead to changes in opinions and behavior (vaccination rates) about COVID and influenza vaccines among Chicago's predominantly Hispanic communities.
Conditions:
🦠 Misinformation 🦠 Influenza 🦠 COVID-19 🦠 Vaccine Hesitancy 🦠 Communication Research 🦠 Health Behavior
🗓️ Study Start (Actual) 30 May 2023
🗓️ Primary Completion (Estimated) 30 June 2027
✅ Study Completion (Estimated) 1 April 2028
👥 Enrollment (Estimated) 1400
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Chicago, Illinois, United States
📍 Chicago, Illinois, United States
📍 Iowa City, Iowa, United States
📍 Ann Arbor, Michigan, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

      Inclusion Criteria:

        Exclusion Criteria:

        • * Exclusion: Plans to stop working as a "promotor" before spring of 2027 (end of data collection planned). People can not participate if they are under the age of 18, or can not understand Spanish and English, or do not provide services in the included zip codes, or do not wish to participate in social media.
    Ages Eligible for Study: 18 Years to 99 Years (ADULT, OLDER_ADULT)
    Sexes Eligible for Study: ALL
    Accepts Healthy Volunteers: Yes

    🗓️ Study Record Dates

    These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

    Study Registration Dates

    • First Submitted 13 May 2024
    • First Submitted that Met QC Criteria 13 May 2024
    • First Posted 16 May 2024

    Study Record Updates

    • Last Update Submitted that Met QC Criteria 11 July 2024
    • Last Update Posted 15 July 2024
    • Last Verified May 2024